NEAT1 and gastric cancer: Based on the ENCORI (Fig. 1) and data analysis, NEAT1 has a significant down-regulation in breast cancer (FC: 0.73, FDR: 0.015) and gastric cancer (FC: 1.81, FDR: 0.0016).